Streetbeat News

Products Services

NVDA

Nvidia experienced a significant downturn from November 2021 to October 2022 with a 68% decline but rebounded with a 529% increase due to demand in AI and gaming. Its market cap reached $1.8 trillion, establishing it as a major global player. The anticipated Q4 earnings are $4.53 per share, up from last year's $0.88, reflecting investor confidence in Nvidia's future. The stock surged 47% this year, adding to a 234% increase in 2023, and closed at $726.13 after the latest trading session.

Portfolio Pulse from Zaheer Anwari

February 20, 2024 | 7:20 pm

RIVN

Rivian Automotive, Inc. (NASDAQ:RIVN) shares are trading lower ahead of its Q4 earnings report. The company announced expansion into Europe and the unveiling of a new SUV, the R2. Barclays analyst Dan Levy downgraded Rivian's stock from Overweight to Equal-Weight with a price target reduction from $25 to $16, citing a slowdown in the EV market. Rivian is expected to report a loss of $1.32 per share and revenue of $1.262 billion. Analysts have mixed ratings on RIVN, with an average 12-month price target of $20.14.

Portfolio Pulse from Erica Kollmann

February 20, 2024 | 7:12 pm

AMZN

RIVN

Rivian Automotive Inc (NASDAQ:RIVN) is set to report its Q4 financial results, with analysts expecting a significant revenue increase to $1.262 billion from last year's $663.0 million, and a reduced loss of $1.32 per share. Despite beating earnings estimates in recent quarters, several analysts have downgraded RIVN due to the overall weakness in the EV sector and potential challenges in meeting its 2024 gross margin profitability target. Key items for the upcoming earnings include updates on 2024 production, deliveries, and details on the R2 model debut.

Portfolio Pulse from Chris Katje

February 20, 2024 | 6:41 pm

CMND

SPRC

SciSparc Ltd. (NASDAQ:SPRC) and Clearmind Medicine Inc. (NASDAQ:CMND) announced the submission of three international patent applications for novel proprietary combinations of psychedelic compounds, boosting their shares. This collaboration has led to 11 patent applications, aiming to strengthen their position in the psychedelic drug development market.

Portfolio Pulse from Erica Kollmann

February 20, 2024 | 6:29 pm

TEVA

Teva Pharmaceutical Industries (NYSE:TEVA) CEO Richard Francis confirmed the company will not split into two entities, focusing on a unified approach to manage its generics and branded drugs businesses. Despite challenges, Teva remains optimistic, leveraging collaborations with Israeli universities for R&D. The company plans to divest its API business, valued at $1 billion, expecting significant interest. The divestiture is aimed to be completed in the first half of 2025, with TEVA shares currently up 0.88% at $13.14.

Portfolio Pulse from Vandana Singh

February 20, 2024 | 6:24 pm

AGRI

DFS

EVA

FLR

MEDS

MNPR

VZIO

Fluor Corporation's shares fell by 7.7% following its Q4 results, with earnings beating estimates but sales missing expectations. Other stocks moved significantly in Tuesday's session, with notable gainers including TRxADE HEALTH, AgriFORCE Growing Systems, and Monopar Therapeutics, among others, due to various positive announcements. Losers included RAPT Therapeutics, MicroCloud Hologram, and Summit Therapeutics, primarily due to negative news or disappointing results.

Portfolio Pulse from Avi Kapoor

February 20, 2024 | 6:21 pm

ROKU

Recent analysis of options activity for Roku (NASDAQ:ROKU) reveals a bearish sentiment among investors, with 65% of trades being bearish and 34% bullish. The options trades have focused on a price range of $50.0 to $120.0 for Roku. Notable trades include a mix of bearish, bullish, and neutral sentiments with varying expiration dates and strike prices. Roku, a leading streaming platform, has seen a recent price drop of -5.5%, with its stock currently trading at $68.04. The company is anticipated to release its earnings in 64 days.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 6:15 pm

ARM

NVDA

SSNLF

Samsung Electronics Co (OTC:SSNLF) and Arm Holdings Plc (NASDAQ:ARM) have announced a collaboration to develop the next-generation Arm Cortex-X CPU using Samsung's Gate-All-Around process technology. This partnership aims to drive innovations in the semiconductor industry, focusing on a 2-nanometer AI chipset for mobile computing and data centers. Meanwhile, Nvidia Corp (NASDAQ:NVDA) increased its stake in Arm Holdings, which has seen its shares surge by 119% over the past quarter following its IPO.

Portfolio Pulse from Anusuya Lahiri

February 20, 2024 | 6:08 pm

AXSM

Axsome Therapeutics Inc (NASDAQ:AXSM) reported a Q4 2023 net loss of $(2.08) per share, missing consensus estimates and deeper than the previous year's $(1.41) per share. Despite this, Q4 revenues rose to $71.53 million from $24.37 million a year ago, beating consensus estimates of $67.69 million. The revenue increase was driven by sales of its oral antidepressant Auvelity and sleep disorder drug Sunosi, with significant year-over-year growth. The company also updated its pipeline milestones, including delays in new drug application submissions and clinical trial initiations.

Portfolio Pulse from Vandana Singh

February 20, 2024 | 6:05 pm

ETH-USD

On Monday, 7,114.69 Ether (ETH) worth approximately $20.66 million was burned, permanently removing it from circulation. This action follows the Ethereum blockchain's EIP-1159 upgrade implemented on August 5, 2021, which introduced a variable base fee for transactions that is burned. The current issuance rate of new Ether is 4% per year, expected to decrease to 0.5-1% with the Ethereum 2.0 upgrade, potentially making ETH a deflationary currency. The net annualized issuance rate for Ether was -7.32% yesterday.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 6:00 pm